Awareness activities to increase colorectal cancer screening participation
First written in FY2017-Q1. 7 of 10 entries say "Advanced", first in FY2022. Latest entry: 2026-07-30.
No other company in this theme has enough history to compare yet.
- FY2025AdvancedAnnual report
「This improved buffer solution has already been launched in the market, making mail-in screening possible in high-temperature environments. We will continue to promote higher participation in colorectal cancer screening through the wider adoption of mail-in screening.」
The improved buffer solution for fecal occult blood testing reagents was launched in the market, reaching the stage where mail-in screening can be conducted in high-temperature environments. - FY2022AdvancedAnnual report
「The concepts of web-based screening, mail-in screening, pharmacy-based screening and endoscopic triage have gained acceptance, and we promoted efforts to stimulate demand.」
In addition to the existing awareness activities, efforts to stimulate demand through web-based screening, mail-in screening, pharmacy-based screening and endoscopic triage were advanced. - FY2017RestatedAnnual report
「We conducted awareness activities to increase participation in colorectal cancer screening.」
Awareness activities to increase participation in colorectal cancer screening continue. - FY2017-Q3RestatedAnnual report
「We conducted awareness activities to increase participation in colorectal cancer screening.」
Awareness activities aimed at increasing participation in colorectal cancer screening continue. - FY2017-Q1First statedAnnual report
「We conducted awareness activities to increase participation in colorectal cancer screening.」
Alongside expanding the adoption of domestic fecal occult blood testing products, awareness activities aimed at increasing screening participation have been described independently for the first time.